Navigation Links
New Survey Finds Troubling Data on American Asthma Sufferers

percent), difficulty breathing (19 percent), wheezing (18 percent), tightness in chest (18 percent) and difficulty falling or staying asleep (19 percent). -- The perceived mild symptoms may translate into underdosing: of those taking less than the prescribed dose of their fast-acting inhalers during a flare up, more than six-in-ten parents of child (67 percent) and adult sufferers (61 percent) do so because they do not feel their flare up is severe enough. Medication Use -- Overdosing. Of those asthma sufferers who report taking more of their fast acting inhaler than prescribed, more than half (51 percent) do so because the prescribed dose took too long. -- Switching medications. Nearly half of asthma sufferers (43 percent) have switched controller medications. Almost a quarter (23 percent) switched because they heard about a better controller medication.

Asthma's Impact on Lifestyle

According to adult asthmatics and parents of child sufferers, asthma is a condition that limits activities and affects job and school performance.

    -- One-quarter (26 percent) of all asthma sufferers report asthma limits

       their ability to participate in sports.


    -- About one-in-ten of all asthma sufferers report that their asthma

       impacts certain aspects of their work and school performance

Parents: A Protective Group

Comparing the experiences of adult sufferers with parents of child sufferers reveals a greater level of involvement, concern and anxiety on the part of parents, who may feel they are advocates for their child's health.

    -- Parents of child sufferers (34 percent) are more likely to contact

       their physician than adults (11 percent) when they have questions

       between doctor visits.


    -- Parents describe their child as having mild (46 percent) or moderate

       asthma (44 per
'"/>




Page: 1 2 3 4 5 6 

Related medicine technology :

1. International ENDORSE Study Shows That the Majority of Hospitalized
Patients Surveyed are at Risk for VTE and Many do not Receive
Recommended VTE prophylaxis
2. Women Well-Informed About Breast Cancer, Yet Lacking Knowledge
About Current Treatments, New Survey Finds
3. Waismann Method Survey Reveals Dependency Risk for People Using
Suboxone
4. Hypertension Education Foundation Survey Results Announced At
American Society For Hypertension Annual Meeting Suggests Improved
Control Of High Blood Pressure, But Misconceptions Still Exist
5. Survey: Migraine Patients Taking Potentially Addictive Barbiturate
or Opioid Medications Not Approved by FDA as Migraine Treatments
6. Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate
Dependency Treatment Are Mothers
7. Survey Reveals Significant Public Lack of Diabetes Awareness
8. Medical Journal Publishes First Large-Scale Survey Revealing
Experiences of IPF Patients
9. DVT Awareness Survey Findings for Respondents in High-Risk Groups:
Obese Individuals
10. DVT Awareness Survey Findings: Heart and Respiratory Patients
11. Common Preterm Labor Drug Has More Side Effects Than Alternative,
Finds Study from Packard Childrens Hospital and Stanford
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Survey Finds Troubling Data American Asthma Sufferers
(Date:12/15/2009)... Medical Systems (NYSE: VAR ) announced today ... fiscal year 2010 following the close of regular trading ... will be followed by a teleconference available to all ... release and a link to the conference call webcast ... www.varian.com/investor . To access the teleconference call and ...
(Date:12/15/2009)... Calif., Dec. 15 Genomic Health, Inc. (Nasdaq: ... studies on its Onco type DX® breast cancer ... to predict the likelihood of chemotherapy benefit and recurrence ... were presented at the 32nd Annual CTRC-AACR San Antonio ... in San Antonio, TX. ,, "The breadth of data ...
(Date:12/15/2009)... /PRNewswire-Asia/ -- Sinovac Biotech Ltd. ( SVA),a ... announced today,that Weidong Yin, Chairman, President & ... to be one of 18 nominees for ... CCTV,s Economic Man-of-the-Year is the country,s ... to as the "Oscar Award of the,Chinese ...
Breaking Medicine Technology:Varian Medical Systems Schedules First Quarter FY2010 News Release and Conference Call 2Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 2Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 3Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 4Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 5Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 6Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 7Sinovac's CEO Weidong Yin Nominated for China Central Television's Prestigious Economic Man-of-the-Year Award 2Sinovac's CEO Weidong Yin Nominated for China Central Television's Prestigious Economic Man-of-the-Year Award 3New AMA Ad Emphasizes Common Ground on Health Reform Shares Vision to Fix Broken System 52955 1New AMA Ad Emphasizes Common Ground on Health Reform Shares Vision to Fix Broken System 52955 2HOWARU 28R 29 Protect Clinically Shown to Reduce the Incidence and Severity of Cold and Flu Symptoms in Children 52951 1HOWARU 28R 29 Protect Clinically Shown to Reduce the Incidence and Severity of Cold and Flu Symptoms in Children 52951 2Clyde C Tuggle Senior Vice President at The Coca Cola Company Elected to CASA Board 52947 1Clyde C Tuggle Senior Vice President at The Coca Cola Company Elected to CASA Board 52947 2Clyde C Tuggle Senior Vice President at The Coca Cola Company Elected to CASA Board 52947 3
(Date:12/15/2009)... time and money with comprehensive solution , ... ... Epocrates, Inc., developer of the most popular medical ... new premium software suite for the platform – Epocrates® ... rely on Epocrates products on their iPhone and iPod touch ...
(Date:12/15/2009)... earn your trust as the most caring, conscientious practice you have ... into the Dermatology Center of Dallas, we can help to achieve ... ... TX (PRWEB) December 15, 2009 -- The Dermatology Center of Dallas, ... the arrival of Jeri Beth “J.B.” Foshee, MD in their practice. ...
(Date:12/15/2009)... Telangiectasia , ... (PRWEB) December 10, 2009 -- Millions of men and ... those unsightly clusters of red, blue or purple veins that spider-web across ... like the US, it’s been estimated that 25-30% of women and 10-20% ... ,Although the Veinwave has been available for over 8 years ...
(Date:12/15/2009)... A study in the Dec. 15 issue ... indicates that significant associations exist between parent-reported ... and headaches in young school-aged children. , ... insomnia was 3.3 times more likely in children ... in children with headaches. Nineteen percent of ...
(Date:12/14/2009)... more… , ... Santa Barbara, California ... scientists at University of Michigan, have developed synthetic particles that ... blood cells, including softness, flexibility, and the ability to carry ... natural red blood cells is to carry oxygen, and the ...
Breaking Medicine News(10 mins):Health News:Epocrates Expands iPhone Offerings with New Premium Content 2Health News:Epocrates Expands iPhone Offerings with New Premium Content 3Health News:Jeri Beth “J.B.” Foshee, MD Joins Dermatology Center of Dallas 2Health News:Vein Center & CosMed, Inc. Selected as Exclusive St. Louis Provider of FDA-Cleared Device 2Health News:Insomnia symptoms linked with medical complaints in young school-aged children 2Health News:Insomnia symptoms linked with medical complaints in young school-aged children 3Health News:Synthetic Red Blood Cells Developed 2Health News:Synthetic Red Blood Cells Developed 3
... Protalix,BioTherapeutics, Inc. (Amex: PLX ), noted today ... (GCD), which is used as,an enzyme replacement therapy ... Most Promising Drugs Entering Phase III Trials in ... report published by Thomson Scientific. Thomson,Scientific, a part ...
... Quality/Patient Safety Initiatives; Geared to Reducing ... Operating Room Efficiencies, LAKE FOREST, Ill., Dec. ... outsourced hospital compounded sterile preparations, is,offering availability of ... reducing medication errors and improving OR,efficiencies. The service ...
... No longer are helmets,enough for motorcyclists to ... Motorcycle Cancer?, author Randall Dale,Chipkar considers motorcycle radiation ... may have a higher risk for cancer development ... says,Chipkar. "Is it a paradox that thousands of ...
... and their ... employees, CHICAGO, Dec. ... care costs and help employees,identify their health risks and cut back on ... smoking cessation,plans and counseling to discounted gym memberships and even acupuncture --,can ...
... Foot Health Can Prevent High Heel Hangover, SALEM, N.H., ... burning you feel after a day or night in heels. ... heel hangover can be,eliminated from your life, without having to ... confessed "shoe addicts" but they don,t think about,how the shoes ...
... 3 SGX Pharmaceuticals, Inc.,(Nasdaq: SGXP ) ... new,drug (IND) application to the U.S. Food and ... developed, orally-bioavailable, small,molecule inhibitor of the cMET receptor ... clinical trials of SGX523 for solid tumor cancer,patients ...
Other Medicine News:Health News:Protalix BioTherapeutics' prGCD Named One of the Five Most Promising Drugs Entering Phase III Trials by Thomson Scientific 2Health News:Protalix BioTherapeutics' prGCD Named One of the Five Most Promising Drugs Entering Phase III Trials by Thomson Scientific 3Health News:PharMEDium Announces Availability of Pre-Filled Operating Room Perioperative Compounded Drugs 2Health News:Motorcycle Radiation May Be Linked to Cancer Risk 2Health News:Employee Health Includes Financial Health, Too 2Health News:High Heel Health 2Health News:SGX Pharmaceuticals Submits Investigational New Drug Application for SGX523, a Highly Potent, Selective, Orally Bioavailable cMET Inhibitor 2Health News:SGX Pharmaceuticals Submits Investigational New Drug Application for SGX523, a Highly Potent, Selective, Orally Bioavailable cMET Inhibitor 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: